Skip to content

Life sciences

Filters

Showing results for


Clear all
Zelta ranks as Major Contender in Everest Group’s 2024 Clinical Data and Analytics PEAK Matrix report

We’re excited to announce that Zelta has been positioned as a Major Contender in the...

By Jennifer Duff | 3 min. read

Let the use case decide: The Zelta way on AI and supervised machine learning

For decades, when people thought of artificial intelligence (AI) what usually...

By Walker Bradham | 2 min. read

Five questions to ask before choosing a real-world data provider

When you’re working with real-world data (RWD) in a clinical trial setting, you must...

By Liisa Palmer | 6 min. read

Zelta user success stories: Faster timelines, cleaner data, in-house flexibility

This month we’re profiling just a few of the CROs, sponsors, biotech, and pharma...

By Kofi Darkoh | 4 min. read

Mortality data: Driving health research forward

Learn how the MarketScan Mortality Database can help generate insights, examine...

By Liisa Palmer | 2 min. read

The missing puzzle piece: Linking MarketScan claims data with Veradigm EHR data

This new healthcare database unlocks the whole picture of patient care at an...

By Marcy Tatsch | 2 min. read

Zelta ranked as a Leader in Everest Group’s 2024 EDC Products PEAK® Matrix Assessment

We’re excited to announce that Zelta has been officially ranked as a Leader in the...

By Jennifer Duff | 4 min. read

Gene therapy: How Veristat cut trial database costs by 30%

This piece originally appeared in Pharmaceutical Technology. The gene therapy...

By Jennifer Duff | 7 min. read

Optimize sample size and observation time: A case for employer-sourced administrative claims data

Closed administrative claims databases capture the complete range of healthcare...

By Merative | 5 min. read

Untapped opportunities: Fulfilling the promise of decentralized clinical trials

This piece originally appeared in Pharmaceutical Technology. The uptake of...

By Wes Fishburne | 6 min. read

4 ways the vaccine rush is defining infectious disease trends for CROs in 2024

This piece originally appeared on Pharmaceutical Technology. The global healthcare...

By Jennifer Duff | 5 min. read

Three real-world data research and regulatory trends to watch in 2024 and beyond

The Professional Society for Health Economics and Outcomes Research, known as...

By Merative | 5 min. read

The future of Zelta on display at the 2024 User Conference

That’s a wrap on the 2nd annual Zelta User Conference! We had a wonderful,...

By Jennifer Duff | 5 min. read

Oncology in 2024: The clinical trial trends reshaping the role of CROs

This piece originally appeared on Pharmaceutical Technology. Oncology is the most...

By Jennifer Duff | 7 min. read

Measure the impacts of patient productivity loss and caregiver burden with real-world data

When patients are struck with illness, their quality of life and well-being are of...

By Liisa Palmer | 5 min. read

Four ways a holistic ecosystem for clinical trials can help boost ROI

This piece originally appeared on Clinical Leader Clinical trials are complex and...

By Jennifer Duff | 9 min. read

Advance rare diseases research with closed claims real-world data

MarketScan real-world data has been used to assess illness burden of rare diseases,...

By Liisa Palmer | 8 min. read

Zelta surpasses 4,000 clinical trial studies

February 2024 marked a major milestone for Zelta: the platform has now hosted over...

By Jennifer Duff | 3 min. read

What’s more important: Real-world data quality or speed?

Here is what executives from biopharma and medical device companies had to say...

By Liisa Palmer | 2 min. read

Can Your Clinical Trial Design Handle Mid-Study Changes?

As clinical research advances, the pharmaceutical and biotech industries...

By Walker Bradham | 7 min. read

Zelta expands its clinical trial ecosystem with a new partnership

At Zelta, we understand that collaboration is the name of the game when it comes to...

By Merative | 2 min. read

Lifesaving oncology research deserves cutting-edge solutions

The race to develop novel, advanced therapeutics for cancer patients is fast and...

By Jennifer Duff | 7 min. read

New report confirms Zelta by Merative is a Major Contender

Merative has been named a Major Contender in Everest Group’s Life Sciences Clinical...

By Shannon Reilly | 5 min. read

Looking beyond the bump with real-world evidence

Recent moves by the U.S. Federal Drug Administration (FDA) to open clinical studies...

By Liisa Palmer | 4 min. read

Three years after COVID-19, the conversation around DCTs is shifting again

While interest in decentralized clinical trials (DCTs) has been heating up lately,...

By Wes Fishburne | 6 min. read

The disconnect between clinical trial technology and legacy habits

In today’s age of cloud computing and data integration solutions, there are simple...

By Jennifer Duff | 4 min. read

Merative Clinical Development has a new name

General Manager Jennifer Duff describes what the new name means for Merative’s...

By Jennifer Duff | 2 min. read

Questions to ask when managing drug shortages

Drug shortages are nothing new, but the COVID-19 pandemic exacerbated this...

By Merative | 1 min. read

Connecting with the clinical development community

The time it takes to design, launch and complete clinical trials is a problem many...

By Jennifer Duff | 2 min. read

Will DCTs finally democratize clinical trials?

Zelta Product Leader Walker Bradham and Senior Product Manager Wes Fishburne...

By Walker Bradham | 4 min. read

Cardiovascular image and data management: A technical and clinical evolution

By Merative | 4 min. read

Is real-world data the real deal?

Real-world data is Liisa’s world. After receiving her PhD in health policy and...

By Liisa Palmer | 4 min. read

Beyond KLAS rankings: building client relationships at Merative

By David Gruen | 3 min. read